Results 21 to 30 of about 8,413,144 (169)
Updated insights into the molecular pathogenesis of canine atopic dermatitis
Veterinary Dermatology, Volume 36, Issue 4, Page 375-384, August 2025.Abstract Atopic dermatitis (AD) is a common and chronic inflammatory skin disease with frequent relapses. The genomics revolution has greatly contributed and revolutionised our knowledge of human AD; understanding the molecular skin fingerprint of AD and associated pathogenic immune pathways has led to preclinical assessments of several novel ...
Frane Banovic
wiley +1 more source
The Clinical Value of PET-CT in the Diagnosis of Pre-pulseless Takayasu's Arteritis Presenting as Fever of Unknown Origine [PDF]
, 2022 BackgroundTakayasu's arteritis (TAK) presenting as fever of unknown origin (FUO) is rare in clinic. Diagnosis is difficult in the early stageas the non-specific clinical symptoms and signs, the lack of imaging findings of great artery stenosis and ...
ZENG Keqin, YIN Yufeng, REN Tian, ZHOU Erye, WANG Mingjun, WU Jian
core +1 more source
Identification of Candidate Plasma Altered miRNA Associated with Bone Metastasis of Lung Cancer [PDF]
, 2016 目的：应用高通量miRNA芯片及荧光定量PCR技术筛选及鉴定肺癌骨转移血浆中差异表达的miRNA。 方法：搜集2013至2015年在厦门大学附属第一医院入院的45例肺癌病人外周血标本。选取4例肺癌骨转移与4例肺癌无骨转移病人血浆，应用miRNA芯片技术对差异表达的miRNA进行筛选。应用IPA分析差异miRNA参入的信号通路。应用Real-timePCR检测候选差异表达miRNA，进行验证。 结果：通过比对，成功建立了肺癌骨转移与肺癌无骨转移血浆miRNA芯片表达谱，筛选出了12个差异表达miRNA ...
王文一
core
Long‐term use of lokivetmab in dogs with atopic dermatitis
Veterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper +2 more
wiley +1 more source
Mechanistic study of TREM2 mutations in increasing the risk of neurodegenerative diseases [PDF]
, 2016 2型髓系细胞触发受体（Triggeringreceptorexpressedonmyeliodcells2，TREM2）是中枢神经系统（centralnervoussystem，CNS）中主要表达于小胶质细胞表面并参与机体固有免疫的一种受体蛋白，与其接头蛋白酪氨酸激酶结合蛋白（DNAXactivatingproteinof12kDa，DAP12）形成TREM2/DAP12复合物，从而调节小胶质细胞中的炎症反应和吞噬功能。TREM2属于Ⅰ型跨膜蛋白，其胞外段经过蛋白酶切割后产生可溶形式TREM2 ...
王哲
core
Research Progress on the Influence of Intermittent Fasting on Cardiovascular Disease Risk Factors [PDF]
, 2022 In recent years, the prevalence and mortality of cardiovascular diseases in China have shown a significant upward trend, cardiovascular disease has become a major disease endangering the health of Chinese residents.
CUI Yanru, CEN Qiuyu, WEI Juanfang, WANG Wenchun, ZHANG Anren
core +1 more source
Veterinary Dermatology, Volume 35, Issue 6, Page 595-604, December 2024.Background – Mycobacterium cell wall fraction (MCWF) is derived from nonpathogenic Mycobacterium phlei and is used as an immunomodulatory compound in clinical practice, yet its mode‐of‐action requires further research. Objective – To evaluate the host response to MCWF in canine peripheral blood mononuclear cells (PBMCs) by using enzyme‐linked ...
Robert Ward +9 more
wiley +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 2021 目的探讨白茅苷对链脲佐菌素（STZ）诱导的I型糖尿病幼龄鼠肝损伤、过氧化应激和免疫应答的影响。方法50只BALB/c幼龄鼠分为健康对照组、模型组、模型+3 mg/kg白茅苷组、模型+6 mg/kg白茅苷组、模型+12 mg/kg白茅苷组（n=10）。糖耐量实验检测各组小鼠空腹血糖、血清胰岛素和肥胖指数，自动生化分析仪测定血清中高密度脂蛋白、低密度脂蛋白、甘油三酯、总胆固醇含量，苏木精-伊红染色观察肝损伤程度，末端标记染色观察细胞凋亡情况，试剂盒检测超氧化物歧化酶（SOD）和丙二醛（MDA）含量水平 ...
丁艳琴 +4 more
doaj
The phosphorylation of BAG3 by CDK5 and its roles in astrocytes [PDF]
, 2016 细胞周期素依赖性蛋白激酶5（Cyclin-DependentKinase5，CDK5)是细胞周期蛋白依赖性丝氨酸/苏氨酸蛋白激酶家族中的一个成员，在神经系统的发育中发挥了至关重要的作用。CDK5的调节亚基P35、P39是神经系统特异性表达的蛋白，因此赋予了CDK5在神经系统中特异的激酶活性，使CDK5在调控神经递质传递，神经元凋亡等方面发挥了重要作用。对于CDK5的研究一直集中在对其新底物的发现和鉴定上，至今为止有40余个CDK5的底物被鉴定出来。作为脯氨酸依赖性蛋白激酶，CDK5可以特异磷酸化包含有 ...
张冠云
core
Clinical Effect of Early Application of Self-prescribed Yiqihuoxue Decoction on Prevention and Treatment of Depressive Symptoms after Acute Myocardial Infarction [PDF]
, 2022 BackgroundPost-acute myocardial infarction (AMI) patients are prone to depression and other negative emotions. Current treatment for post-AMI patients with depression is anti-myocardial infarction treatment plus anti-depression treatment, in the ...
WANG Mengxi, LIU Qian, SHEN Le, CHEN Xiaohu
core +1 more source